UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Highly Efficient Genome Editing of Murine and Human Hematopoietic Progenitor Cells by CRISPR/Cas9

Cell reports (Cambridge), 2016-10, Vol.17 (5), p.1453-1461

2016

Volltextzugriff (PDF)

Banking on virus-specific T cells to fulfill the need for off-the-shelf cell therapies

Blood, 2023-02, Vol.141 (8), p.877-885

2023

Volltextzugriff (PDF)

Adoptive T-Cell Therapy for Epstein-Barr Virus-Related Lymphomas

Journal of clinical oncology, 2021-02, Vol.39 (5), p.514-524

2021

Volltextzugriff (PDF)

Tonic 4-1BB Costimulation in Chimeric Antigen Receptors Impedes T Cell Survival and Is Vector-Dependent

Cell reports (Cambridge), 2017-10, Vol.21 (1), p.17-26

2017

Volltextzugriff (PDF)

CD70-specific CAR T cells have potent activity against acute myeloid leukemia without HSC toxicity

Blood, 2021-07, Vol.138 (4), p.318-330

2021

Volltextzugriff (PDF)

CD70-specific CAR T cells have potent activity against acute myeloid leukemia without HSC toxicity

Blood, 2021-07, Vol.138 (4), p.318-330

2021

Volltextzugriff (PDF)

CAR T Cells Administered in Combination with Lymphodepletion and PD-1 Inhibition to Patients with Neuroblastoma

Molecular therapy, 2017-09, Vol.25 (9), p.2214-2224

2017

Volltextzugriff (PDF)

Thunder and Lightning: Immunotherapy and Oncolytic Viruses Collide

Molecular therapy, 2011-06, Vol.19 (6), p.1008-1016

2011

Volltextzugriff (PDF)

Clinical and immunological responses after CD30-specific chimeric antigen receptor-redirected lymphocytes

The Journal of clinical investigation, 2017-09, Vol.127 (9), p.3462-3471

2017

Volltextzugriff (PDF)

Tumor indoleamine 2,3-dioxygenase (IDO) inhibits CD19-CAR T cells and is downregulated by lymphodepleting drugs

Blood, 2015-06, Vol.125 (25), p.3905-3916

2015

Volltextzugriff (PDF)

Anti-CD30 CAR-T Cell Therapy in Relapsed and Refractory Hodgkin Lymphoma

Journal of clinical oncology, 2020-11, Vol.38 (32), p.3794-3804

2020

Volltextzugriff (PDF)

Inducible Apoptosis as a Safety Switch for Adoptive Cell Therapy

The New England journal of medicine, 2011-11, Vol.365 (18), p.1673-1683

2011

Volltextzugriff (PDF)

T-cell therapy in the treatment of post-transplant lymphoproliferative disease

Nature reviews. Clinical oncology, 2012-09, Vol.9 (9), p.510-519

2012

Volltextzugriff (PDF)

Human Epidermal Growth Factor Receptor 2 (HER2) -Specific Chimeric Antigen Receptor-Modified T Cells for the Immunotherapy of HER2-Positive Sarcoma

Journal of clinical oncology, 2015-05, Vol.33 (15), p.1688-1696

2015

Volltextzugriff (PDF)

NK Cells Expressing a Chimeric Activating Receptor Eliminate MDSCs and Rescue Impaired CAR-T Cell Activity against Solid Tumors

Cancer immunology research, 2019-03, Vol.7 (3), p.363-375

2019

Volltextzugriff (PDF)

Current challenges for CAR T‐cell therapy of acute myeloid leukemia

Transfusion (Philadelphia, Pa.), 2019-04, Vol.59 (4), p.1171-1173

2019

Volltextzugriff (PDF)

Clinical responses with T lymphocytes targeting malignancy-associated κ light chains

The Journal of clinical investigation, 2016-07, Vol.126 (7), p.2588-2596

2016

Volltextzugriff (PDF)

Off-the-Shelf Virus-Specific T Cells to Treat BK Virus, Human Herpesvirus 6, Cytomegalovirus, Epstein-Barr Virus, and Adenovirus Infections After Allogeneic Hematopoietic Stem-Cell Transplantation

Journal of clinical oncology, 2017-11, Vol.35 (31), p.3547-3557

2017

Volltextzugriff (PDF)

In Vivo Fate and Activity of Second- versus Third-Generation CD19-Specific CAR-T Cells in B Cell Non-Hodgkin’s Lymphomas

Molecular therapy, 2018-12, Vol.26 (12), p.2727-2737

2018

Volltextzugriff (PDF)

Improving Chimeric Antigen Receptor-Modified T Cell Function by Reversing the Immunosuppressive Tumor Microenvironment of Pancreatic Cancer

Molecular therapy, 2017-01, Vol.25 (1), p.249-258

2017

Volltextzugriff (PDF)

Adoptive T-Cell Immunotherapy

Current topics in microbiology and immunology, 2015, Vol.391, p.427

2015

Volltextzugriff (PDF)

Treatment of Acute Myeloid Leukemia with T Cells Expressing Chimeric Antigen Receptors Directed to C-type Lectin-like Molecule 1

Molecular therapy, 2017-09, Vol.25 (9), p.2202-2213

2017

Volltextzugriff (PDF)

Constitutive Signaling from an Engineered IL7 Receptor Promotes Durable Tumor Elimination by Tumor-Redirected T Cells

Cancer discovery, 2017-11, Vol.7 (11), p.1238-1247

2017

Volltextzugriff (PDF)

CD28 costimulation improves expansion and persistence of chimeric antigen receptor-modified T cells in lymphoma patients

The Journal of clinical investigation, 2011-05, Vol.121 (5), p.1822-1826

2011

Volltextzugriff (PDF)

Sustained Complete Responses in Patients With Lymphoma Receiving Autologous Cytotoxic T Lymphocytes Targeting Epstein-Barr Virus Latent Membrane Proteins

Journal of clinical oncology, 2014-03, Vol.32 (8), p.798-808

2014

Volltextzugriff (PDF)

1 – 25 von 505

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(444)
Mit Volltextzugriff
(452)

Publikationsform

Sprache

Englisch
(504)
Japanisch
(30)

Erscheinungsjahr

n.n

Thema

Science & Technology
(261)
Life Sciences & Biomedicine
(256)
Humans
(249)
Immunotherapy
(106)
Hematology
(91)
Biological And Medical Sciences
(90)
Medicine, Research & Experimental
(90)
Research & Experimental Medicine
(90)
T-Lymphocytes, Cytotoxic - Immunology
(80)
Medical Sciences
(79)
Immunology
(69)
Male
(69)
Oncology
(69)
Female
(67)
Herpesvirus 4, Human - Immunology
(67)
Epstein-Barr Virus
(63)
Animals
(62)
T-Lymphocytes - Immunology
(58)
Antigens
(56)
Lymphocytes
(56)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Highly Efficient Genome Editing of Murine and Human Hematopoietic Progenitor Cells by CRISPR/Cas9

Banking on virus-specific T cells to fulfill the need for off-the-shelf cell therapies

Adoptive T-Cell Therapy for Epstein-Barr Virus-Related Lymphomas

Tonic 4-1BB Costimulation in Chimeric Antigen Receptors Impedes T Cell Survival and Is Vector-Dependent

CD70-specific CAR T cells have potent activity against acute myeloid leukemia without HSC toxicity

CD70-specific CAR T cells have potent activity against acute myeloid leukemia without HSC toxicity

CAR T Cells Administered in Combination with Lymphodepletion and PD-1 Inhibition to Patients with Neuroblastoma

Thunder and Lightning: Immunotherapy and Oncolytic Viruses Collide

Clinical and immunological responses after CD30-specific chimeric antigen receptor-redirected lymphocytes

Tumor indoleamine 2,3-dioxygenase (IDO) inhibits CD19-CAR T cells and is downregulated by lymphodepleting drugs

Anti-CD30 CAR-T Cell Therapy in Relapsed and Refractory Hodgkin Lymphoma

Inducible Apoptosis as a Safety Switch for Adoptive Cell Therapy

T-cell therapy in the treatment of post-transplant lymphoproliferative disease

Human Epidermal Growth Factor Receptor 2 (HER2) -Specific Chimeric Antigen Receptor-Modified T Cells for the Immunotherapy of HER2-Positive Sarcoma

NK Cells Expressing a Chimeric Activating Receptor Eliminate MDSCs and Rescue Impaired CAR-T Cell Activity against Solid Tumors

Current challenges for CAR T‐cell therapy of acute myeloid leukemia

Clinical responses with T lymphocytes targeting malignancy-associated κ light chains

Off-the-Shelf Virus-Specific T Cells to Treat BK Virus, Human Herpesvirus 6, Cytomegalovirus, Epstein-Barr Virus, and Adenovirus Infections After Allogeneic Hematopoietic Stem-Cell Transplantation

In Vivo Fate and Activity of Second- versus Third-Generation CD19-Specific CAR-T Cells in B Cell Non-Hodgkin’s Lymphomas

Improving Chimeric Antigen Receptor-Modified T Cell Function by Reversing the Immunosuppressive Tumor Microenvironment of Pancreatic Cancer

Adoptive T-Cell Immunotherapy

Treatment of Acute Myeloid Leukemia with T Cells Expressing Chimeric Antigen Receptors Directed to C-type Lectin-like Molecule 1

Constitutive Signaling from an Engineered IL7 Receptor Promotes Durable Tumor Elimination by Tumor-Redirected T Cells

CD28 costimulation improves expansion and persistence of chimeric antigen receptor-modified T cells in lymphoma patients

Sustained Complete Responses in Patients With Lymphoma Receiving Autologous Cytotoxic T Lymphocytes Targeting Epstein-Barr Virus Latent Membrane Proteins

Suchergebnisse filtern